Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol to investigate Parkinson’s patient-derived dopaminergic neurons by live-cell microscopy and oxidized dopamine assays

STAR Protocols(2024)10.1016/j.xpro.2024.102889Source: DataRank Database

Protocol to investigate Parkinson’s patient-derived dopaminergic neurons by live-cell microscopy and oxidized dopamine assays is a research paper published in STAR Protocols (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (30)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Dimitri Krainc ORCID,Pingping Song ORCID

Live enrichment

PubMed:38341851 PMC:PMC10867435

National Cancer Institute

Grant: CCSG P30 CA060553

National Institutes of Health

Grant: R01NS076054

National Institutes of Health

Grant: R37 NS096241

National Institutes of Health

Grant: R35 NS122257

NCI NIH HHS

Grant: P30 CA060553

National Institutes of Health

Grant: 4R37NS096241-05

The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein

National Institutes of Health

Grant: 5R01NS076054-05

The Role of Lysosomal Glucocerebrosidase in Synucleinopathies

National Institutes of Health

Grant: 5R35NS122257-05

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease

National Institutes of Health

Grant: 5P30CA060553-12

The Robert H.Lurie Comprehensive Cancer Center

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.xpro.2024.102889

publisherhttps://api.elsevier.com/content/article/PII:S2666166724000546?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166724000546?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10867435/pdf/main.pdf

repositoryhttps://doaj.org/article/d703a39716e14505b039adcd886a02e3

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicineHumansDopamineDopaminergic NeuronsParkinson DiseaseMicroscopyInduced Pluripotent Stem CellsUbiquitin-Protein Ligases

MeSH Terms

HumansParkinson DiseaseDopamineUbiquitin-Protein LigasesMicroscopyInduced Pluripotent Stem CellsDopaminergic Neurons

Keywords

Cell biologyNeuroscienceStem CellsMicroscopyScience (General)DopamineDopaminergic NeuronsUbiquitin-Protein LigasesInduced Pluripotent Stem CellsParkinson DiseaseQ1-390ProtocolHumans

Sustainable Development Goals

SDG 3: 3. Good health